JP5763676B2 - カルコン含有口腔ケア配合物の色の変化 - Google Patents
カルコン含有口腔ケア配合物の色の変化 Download PDFInfo
- Publication number
- JP5763676B2 JP5763676B2 JP2012548121A JP2012548121A JP5763676B2 JP 5763676 B2 JP5763676 B2 JP 5763676B2 JP 2012548121 A JP2012548121 A JP 2012548121A JP 2012548121 A JP2012548121 A JP 2012548121A JP 5763676 B2 JP5763676 B2 JP 5763676B2
- Authority
- JP
- Japan
- Prior art keywords
- color
- oral care
- chak4
- composition
- mouthwash
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000203 mixture Substances 0.000 title claims description 92
- DQFBYFPFKXHELB-UHFFFAOYSA-N Chalcone Natural products C=1C=CC=CC=1C(=O)C=CC1=CC=CC=C1 DQFBYFPFKXHELB-UHFFFAOYSA-N 0.000 title claims description 7
- 235000005513 chalcones Nutrition 0.000 title claims description 7
- DQFBYFPFKXHELB-VAWYXSNFSA-N trans-chalcone Chemical compound C=1C=CC=CC=1C(=O)\C=C\C1=CC=CC=C1 DQFBYFPFKXHELB-VAWYXSNFSA-N 0.000 title claims description 4
- 238000009472 formulation Methods 0.000 title description 20
- 239000002324 mouth wash Substances 0.000 claims description 37
- 229940051866 mouthwash Drugs 0.000 claims description 32
- 210000003296 saliva Anatomy 0.000 claims description 22
- 238000000034 method Methods 0.000 claims description 17
- SFDANOZEVFTUOG-VQHVLOKHSA-N (e)-3-(4-hydroxy-3-methoxyphenyl)-1-phenylprop-2-en-1-one Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)C=2C=CC=CC=2)=C1 SFDANOZEVFTUOG-VQHVLOKHSA-N 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 2
- CKQVSNZAXTXQTJ-UHFFFAOYSA-N 2,4-dihydroxy-1,5-diphenylpenta-1,4-dien-3-one Chemical compound C=1C=CC=CC=1C=C(O)C(=O)C(O)=CC1=CC=CC=C1 CKQVSNZAXTXQTJ-UHFFFAOYSA-N 0.000 claims 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 16
- 239000000463 material Substances 0.000 description 13
- -1 alkali metal bicarbonates Chemical class 0.000 description 12
- 150000001875 compounds Chemical class 0.000 description 11
- 239000000243 solution Substances 0.000 description 10
- 230000008859 change Effects 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 210000000214 mouth Anatomy 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 230000008901 benefit Effects 0.000 description 7
- 239000003086 colorant Substances 0.000 description 6
- 239000000551 dentifrice Substances 0.000 description 6
- 235000014113 dietary fatty acids Nutrition 0.000 description 6
- 229930195729 fatty acid Natural products 0.000 description 6
- 239000000194 fatty acid Substances 0.000 description 6
- 230000002265 prevention Effects 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 230000009467 reduction Effects 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 150000001788 chalcone derivatives Chemical class 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 239000002537 cosmetic Substances 0.000 description 4
- 150000004665 fatty acids Chemical class 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 230000000670 limiting effect Effects 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 231100000252 nontoxic Toxicity 0.000 description 4
- 230000003000 nontoxic effect Effects 0.000 description 4
- 239000004094 surface-active agent Substances 0.000 description 4
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 4
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
- 230000003095 anti-phagocytic effect Effects 0.000 description 3
- 239000004599 antimicrobial Substances 0.000 description 3
- 150000001789 chalcones Chemical class 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 235000003599 food sweetener Nutrition 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 3
- 239000000600 sorbitol Substances 0.000 description 3
- 239000003765 sweetening agent Substances 0.000 description 3
- 239000000606 toothpaste Substances 0.000 description 3
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- BACYUWVYYTXETD-UHFFFAOYSA-N N-Lauroylsarcosine Chemical compound CCCCCCCCCCCC(=O)N(C)CC(O)=O BACYUWVYYTXETD-UHFFFAOYSA-N 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000001680 brushing effect Effects 0.000 description 2
- 239000007859 condensation product Substances 0.000 description 2
- 230000007717 exclusion Effects 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- 239000011737 fluorine Substances 0.000 description 2
- 208000007565 gingivitis Diseases 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 230000007407 health benefit Effects 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 239000008223 sterile water Substances 0.000 description 2
- 229940104261 taurate Drugs 0.000 description 2
- 229960003080 taurine Drugs 0.000 description 2
- 229940034610 toothpaste Drugs 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- 239000003981 vehicle Substances 0.000 description 2
- 239000000080 wetting agent Substances 0.000 description 2
- 230000002087 whitening effect Effects 0.000 description 2
- GVSPXQVUXHMUMA-MDWZMJQESA-N (e)-3-(3,5-ditert-butyl-4-hydroxyphenyl)-1-(4-methoxyphenyl)prop-2-en-1-one Chemical compound C1=CC(OC)=CC=C1C(=O)\C=C\C1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 GVSPXQVUXHMUMA-MDWZMJQESA-N 0.000 description 1
- JLPAMKUIIFHLBH-UHFFFAOYSA-N 1,2-dihydroxypropane-1-sulfonic acid Chemical compound CC(O)C(O)S(O)(=O)=O JLPAMKUIIFHLBH-UHFFFAOYSA-N 0.000 description 1
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- LFJJOPDNPVFCNZ-UHFFFAOYSA-N 2-[hexadecanoyl(methyl)amino]acetic acid Chemical class CCCCCCCCCCCCCCCC(=O)N(C)CC(O)=O LFJJOPDNPVFCNZ-UHFFFAOYSA-N 0.000 description 1
- NGOZDSMNMIRDFP-UHFFFAOYSA-N 2-[methyl(tetradecanoyl)amino]acetic acid Chemical class CCCCCCCCCCCCCC(=O)N(C)CC(O)=O NGOZDSMNMIRDFP-UHFFFAOYSA-N 0.000 description 1
- GXJQMKFJQFGQKV-KHPPLWFESA-N 2-[methyl-[(z)-octadec-9-enoyl]amino]ethanesulfonic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)N(C)CCS(O)(=O)=O GXJQMKFJQFGQKV-KHPPLWFESA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- UDIPTWFVPPPURJ-UHFFFAOYSA-M Cyclamate Chemical compound [Na+].[O-]S(=O)(=O)NC1CCCCC1 UDIPTWFVPPPURJ-UHFFFAOYSA-M 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 229940090898 Desensitizer Drugs 0.000 description 1
- 239000005696 Diammonium phosphate Substances 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 244000004281 Eucalyptus maculata Species 0.000 description 1
- 240000001238 Gaultheria procumbens Species 0.000 description 1
- 235000007297 Gaultheria procumbens Nutrition 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 235000019501 Lemon oil Nutrition 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical class [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 244000062730 Melissa officinalis Species 0.000 description 1
- 235000010654 Melissa officinalis Nutrition 0.000 description 1
- 244000024873 Mentha crispa Species 0.000 description 1
- 235000014749 Mentha crispa Nutrition 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 244000227633 Ocotea pretiosa Species 0.000 description 1
- 235000004263 Ocotea pretiosa Nutrition 0.000 description 1
- 235000019502 Orange oil Nutrition 0.000 description 1
- 235000002789 Panax ginseng Nutrition 0.000 description 1
- 206010057249 Phagocytosis Diseases 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 244000197975 Solidago virgaurea Species 0.000 description 1
- 235000000914 Solidago virgaurea Nutrition 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 1
- 244000223014 Syzygium aromaticum Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical class [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 239000003929 acidic solution Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000008055 alkyl aryl sulfonates Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000002272 anti-calculus Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002882 anti-plaque Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 229960005475 antiinfective agent Drugs 0.000 description 1
- 239000008365 aqueous carrier Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 235000019606 astringent taste Nutrition 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical class CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 239000001045 blue dye Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 1
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 235000015111 chews Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical class C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- 239000010630 cinnamon oil Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000000625 cyclamic acid and its Na and Ca salt Substances 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 210000003298 dental enamel Anatomy 0.000 description 1
- MNNHAPBLZZVQHP-UHFFFAOYSA-N diammonium hydrogen phosphate Chemical compound [NH4+].[NH4+].OP([O-])([O-])=O MNNHAPBLZZVQHP-UHFFFAOYSA-N 0.000 description 1
- 229910000388 diammonium phosphate Inorganic materials 0.000 description 1
- 235000019838 diammonium phosphate Nutrition 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical class CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 1
- GVGUFUZHNYFZLC-UHFFFAOYSA-N dodecyl benzenesulfonate;sodium Chemical compound [Na].CCCCCCCCCCCCOS(=O)(=O)C1=CC=CC=C1 GVGUFUZHNYFZLC-UHFFFAOYSA-N 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 150000002169 ethanolamines Chemical class 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 150000002193 fatty amides Chemical class 0.000 description 1
- 239000013020 final formulation Substances 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 210000004195 gingiva Anatomy 0.000 description 1
- 238000011554 guinea pig model Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229960001375 lactose Drugs 0.000 description 1
- 239000010501 lemon oil Substances 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 239000012669 liquid formulation Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000007937 lozenge Substances 0.000 description 1
- 239000011777 magnesium Chemical class 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229960002160 maltose Drugs 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229910052751 metal Chemical class 0.000 description 1
- 239000002184 metal Chemical class 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 229960001047 methyl salicylate Drugs 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000010172 mouse model Methods 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000010502 orange oil Substances 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 201000001245 periodontitis Diseases 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 235000002020 sage Nutrition 0.000 description 1
- 108700004121 sarkosyl Proteins 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229960001462 sodium cyclamate Drugs 0.000 description 1
- 229940080264 sodium dodecylbenzenesulfonate Drugs 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- ZUFONQSOSYEWCN-UHFFFAOYSA-M sodium;2-(methylamino)acetate Chemical class [Na+].CNCC([O-])=O ZUFONQSOSYEWCN-UHFFFAOYSA-M 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000001587 sorbitan monostearate Substances 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- 229940035048 sorbitan monostearate Drugs 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 210000002105 tongue Anatomy 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 238000004383 yellowing Methods 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 239000002888 zwitterionic surfactant Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/35—Ketones, e.g. benzophenone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/42—Colour properties
- A61K2800/45—Colour indicators, e.g. pH- or Redox indicators
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Emergency Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Description
[0001] この出願は2010年1月7日に出願された米国仮特許出願第61/293,079号に対して優先権を主張し、それを本明細書に援用する。
[0010] その記述および具体的な実施例は本発明の態様を示すものであるが、説明の目的のみを意図しており、本発明の範囲を限定することは意図していない。明記された特徴を有する多数の態様の列挙は、追加の特徴を有する他の態様またはその明記された特徴の異なる組み合わせを組み込む他の態様を除外することを意図していない。具体的な実施例は、この発明の組成物および方法をどのように作る、用いる、および実施するかの説明的な目的のために提供されており、なされた行為を列挙すると明示的に記載(すなわち過去形を使用)しない限り、この発明の所与の態様が実施された、または実施されていないという表現であることを意図していない。
[0020] CHAK4が含まれる組成物を用いた研究において、本研究者らは意外にも、ヒトの唾液を含有するあらゆる表面へのその組成物の添加は即時の、かつ独特の(distinctive)色の変化をもたらすことを観察した。唾液がCHAK4を含む組成物に色の移行を引き起こすというこの驚くべき発見は、本発明者らをpHはCHAK4を含む組成物の色に作用を有すると信じるように導いた。
[0036] CHAK4を、無色である塩化セチルピリジニウム(cetylpyridinum chloride)を含有する出発基礎マウスウォッシュ配合物に添加した。その無色のマウスウォッシュに添加されたCHAK4は、そのマウスウォッシュ配合物を黄色に変化させた。0.01重量%から0.05重量%、0.1重量%および0.5重量%の、様々な濃度のCHAK−4を用いた。0.05重量%のCHAK−4に関するマウスウォッシュ配合物の色は、ほとんどオレンジ色のような色へと、最も強い色の変化をもたらした。残りの配合物は鮮やかな黄色であった。
[0037] この実施例は、CHAK4を含むマウスウォッシュ溶液の色への唾液の作用を説明する。マウスウォッシュ溶液を、増大する濃度のCHAK4を用いて、本発明に従って作った。100μlのマウスウォッシュを96ウェルプレート上のウェルに添加した。次いで増大する体積の滅菌したヒトの唾液を、マウスウォッシュを含有するそれぞれのウェルに添加した。
[0040] この実施例は、0.1%のCHAK4を含むマウスウォッシュ溶液の色へのpHの作用を説明する。CHAK4を透明なマウスウォッシュ溶液中に混合し、そのpHを調節した。その溶液は3.8のpHにおいて黄色であり、4.5のpHにおいてアキノキリンソウ色、そして6.8のpHにおいて赤色であった。比較的狭いpHの範囲内で、0.1%のCHAK4を含有する完全なマウスウォッシュ配合物において色の変化を誘導することが可能であった。
[0041] 典型的なマウスウォッシュ配合物およびCHAK4を含有する配合物を、表1で提供する。それぞれのマウスウォッシュ配合物は、CHAK4無しのマウスウォッシュが青色であり、CHAK4を含有するマウスウォッシュ配合物が緑色であるように、青色の染料を含有していた。その最終的な配合物の色は、CHAK4と組み合わせられる着色剤のタイプに依存して調整することができる。
[0042] インビトロの研究は、CHAK4が含まれるマウスウォッシュ組成物における色の変化は、実際の使用におけるすすぎの際に存在するであろう量に匹敵する少量の唾液との混合によりすぐに誘導することができることを示した。
Claims (10)
- 唾液の添加により、および/または組成物のpHの変化により色を変化させることができるカルコン色変化構成要素を含む口腔ケア組成物であって、前記色変化構成要素がフェニル−3−メトキシ−4−ヒドロキシスチリルケトン(CHAK4)を含む、口腔ケア組成物。
- その口腔ケア組成物がマウスウォッシュである、請求項1に記載の口腔ケア組成物。
- そのCHAK4がその組成物の0.01重量%から10重量%までの量で存在する、請求項1または2に記載の口腔ケア組成物。
- そのCHAK4が0.01%から0.05%までの量で存在する、請求項3に記載の口腔ケア組成物。
- その組成物のpHが2から12までの範囲である、請求項1〜4のいずれか1項に記載の口腔ケア組成物。
- その組成物のpHが3.5から5までの範囲である、請求項5に記載の口腔ケア組成物。
- そのマウスウォッシュの0.01重量%から10重量%までの量でフェニル−3−メトキシ−4−ヒドロキシスチリルケトンを含むマウスウォッシュ。
- フェニル−3−メトキシ−4−ヒドロキシスチリルケトン(CHAK4)を口に許容できるキャリヤーに添加することを含む、色変化構成要素を含む口腔ケア組成物を作る方法。
- そのCHAK4がその組成物の0.01重量%から10重量%までの量で添加される、請求項8に記載の方法。
- さらにそのpHがpHが3.5から5.0までの範囲内であるように調節することを含む、請求項8または9に記載の方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US29307910P | 2010-01-07 | 2010-01-07 | |
US61/293,079 | 2010-01-07 | ||
PCT/US2011/020370 WO2011085098A2 (en) | 2010-01-07 | 2011-01-06 | Color change of chalcone-containing oral care formulations |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2013516477A JP2013516477A (ja) | 2013-05-13 |
JP5763676B2 true JP5763676B2 (ja) | 2015-08-12 |
Family
ID=44306144
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2012548121A Expired - Fee Related JP5763676B2 (ja) | 2010-01-07 | 2011-01-06 | カルコン含有口腔ケア配合物の色の変化 |
Country Status (17)
Country | Link |
---|---|
US (2) | US8784779B2 (ja) |
EP (1) | EP2521529B1 (ja) |
JP (1) | JP5763676B2 (ja) |
CN (1) | CN102686211A (ja) |
AR (1) | AR079861A1 (ja) |
AU (1) | AU2011203624B8 (ja) |
BR (1) | BR112012016465A2 (ja) |
CA (1) | CA2786016C (ja) |
CO (1) | CO6541655A2 (ja) |
IN (1) | IN2012DN05919A (ja) |
MX (1) | MX2012007876A (ja) |
MY (1) | MY162834A (ja) |
RU (1) | RU2524631C2 (ja) |
SG (1) | SG182302A1 (ja) |
TW (1) | TWI392513B (ja) |
WO (1) | WO2011085098A2 (ja) |
ZA (1) | ZA201205077B (ja) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2441367T3 (es) | 2009-12-18 | 2014-02-04 | Colgate-Palmolive Company | Chalconas como potenciadores de antibióticos |
US11650186B2 (en) | 2018-10-02 | 2023-05-16 | The Glad Products Company | Thermoplastic films and bags with color changing indicators and methods of making the same |
Family Cites Families (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3522236A (en) * | 1967-05-15 | 1970-07-28 | Int Minerals & Chem Corp | 2',4',6',3 - tetrahydroxy - 4 - n - propoxydihydrochalcone 4'-beta-neohesperidoside and edible compositions containing same |
US3739064A (en) * | 1970-09-30 | 1973-06-12 | Procter & Gamble | Dihydrochalcone sweetening agents |
CH628808A5 (fr) | 1978-02-16 | 1982-03-31 | Cooper Sa | Pate dentifrice permettant un controle du temps de brossage des dents. |
JPS55129215A (en) * | 1979-03-27 | 1980-10-06 | Lion Corp | Composition for oral cavity |
JPS58213706A (ja) | 1982-06-08 | 1983-12-12 | Lion Corp | 歯垢形成抑制用剤 |
FR2622439B1 (fr) * | 1987-11-04 | 1991-07-12 | Rhone Poulenc Chimie | Silice pour compositions dentifrices compatible notamment avec la chlorhexidine |
US5116602A (en) | 1989-09-27 | 1992-05-26 | Colgate-Palmolive Company | Antiplaque oral compositions |
JPH03122645A (ja) * | 1989-10-05 | 1991-05-24 | Nippon Kanko Shikiso Kenkyusho:Kk | ホトレジスト用光吸収材料 |
US5683678A (en) * | 1995-03-09 | 1997-11-04 | The Procter & Gamble Company | Oral compositions |
US6319958B1 (en) | 1998-06-22 | 2001-11-20 | Wisconsin Alumni Research Foundation | Method of sensitizing microbial cells to antimicrobial compound |
ATE361083T1 (de) * | 2000-06-28 | 2007-05-15 | Kikkoman Corp | Antiallergische verbindungen und diese enthaltende medikamente, nahrungsmittel, getränke oder kosmetika sowie verfahren zu deren herstellung |
JP2002121122A (ja) * | 2000-10-13 | 2002-04-23 | Musashino Meneki Kenkyusho:Kk | 口腔用組成物 |
JP2003122645A (ja) | 2001-10-11 | 2003-04-25 | Noritsu Koki Co Ltd | 写真処理装置 |
US20060078633A1 (en) * | 2002-12-27 | 2006-04-13 | Na Min K | Extract of cercis chinensis having anti-oxidant activity and anti-aging activity, and cosmetical composition containing the extract for anti-oxidation, skin-aging protection and wrinkle improvement |
US20040208908A1 (en) | 2003-04-16 | 2004-10-21 | The Trustees Of Columbia University In The City Of New York | Antimicrobial medical articles containing a synergistic combination of anti-infective compounds and octoxyglycerin |
CA2532730C (en) | 2003-07-17 | 2013-02-26 | The Trustees Of Columbia University In The City Of New York | Antimicrobial compositions containing synergistic combinations of quaternary ammonium compounds and essential oils and/or constituents thereof |
US20050084551A1 (en) * | 2003-09-26 | 2005-04-21 | Jensen Claude J. | Morinda citrifolia-based oral care compositions and methods |
JP2005298357A (ja) | 2004-04-07 | 2005-10-27 | Lion Corp | 口腔用組成物 |
WO2005123023A1 (en) | 2004-06-10 | 2005-12-29 | Segan Industries, Inc. | Plural activating optical change toothpastes, stimuli and elements |
US20060141072A1 (en) | 2004-12-29 | 2006-06-29 | Arvanitidou Evangelia S | Oxidation resistant dentifrice compositions |
US20060222601A1 (en) * | 2005-03-29 | 2006-10-05 | Sabnis Ram W | Oral care compositions with color changing indicator |
GB0509422D0 (en) | 2005-05-09 | 2005-06-15 | Mabtech Ab | Membranes |
DE102005044156A1 (de) | 2005-09-15 | 2007-03-29 | Riemser Arzneimittel Ag | Substituierte Acetophenonderivate |
JP4948044B2 (ja) | 2006-06-02 | 2012-06-06 | 三栄源エフ・エフ・アイ株式会社 | プラーク形成抑制剤、または抗う蝕菌剤 |
JP2008031076A (ja) * | 2006-07-28 | 2008-02-14 | Nippon Seibutsu Kagaku Kenkyusho:Kk | アディポネクチン産生促進剤 |
CN101147724A (zh) | 2006-12-04 | 2008-03-26 | 好维股份有限公司 | 含甘草黄酮提取物的口腔药物或口腔卫生产品 |
US8778987B2 (en) * | 2007-03-13 | 2014-07-15 | Symrise Ag | Use of 4-hydroxychalcone derivatives for masking an unpleasant taste |
WO2009093584A1 (ja) * | 2008-01-23 | 2009-07-30 | Kaneka Corporation | 植物由来の高尿酸血症の予防または改善剤 |
US8906349B2 (en) | 2009-08-12 | 2014-12-09 | Colgate-Palmolive Company | Oral care composition |
ES2441367T3 (es) * | 2009-12-18 | 2014-02-04 | Colgate-Palmolive Company | Chalconas como potenciadores de antibióticos |
-
2011
- 2011-01-06 IN IN5919DEN2012 patent/IN2012DN05919A/en unknown
- 2011-01-06 CN CN2011800055422A patent/CN102686211A/zh active Pending
- 2011-01-06 CA CA2786016A patent/CA2786016C/en not_active Expired - Fee Related
- 2011-01-06 TW TW100100462A patent/TWI392513B/zh not_active IP Right Cessation
- 2011-01-06 AU AU2011203624A patent/AU2011203624B8/en not_active Ceased
- 2011-01-06 EP EP11700584.3A patent/EP2521529B1/en active Active
- 2011-01-06 MY MYPI2012002992A patent/MY162834A/en unknown
- 2011-01-06 BR BR112012016465A patent/BR112012016465A2/pt not_active IP Right Cessation
- 2011-01-06 US US13/520,751 patent/US8784779B2/en active Active
- 2011-01-06 WO PCT/US2011/020370 patent/WO2011085098A2/en active Application Filing
- 2011-01-06 JP JP2012548121A patent/JP5763676B2/ja not_active Expired - Fee Related
- 2011-01-06 SG SG2012048575A patent/SG182302A1/en unknown
- 2011-01-06 MX MX2012007876A patent/MX2012007876A/es active IP Right Grant
- 2011-01-06 RU RU2012133558/15A patent/RU2524631C2/ru not_active IP Right Cessation
- 2011-01-07 AR ARP110100058A patent/AR079861A1/es unknown
-
2012
- 2012-07-06 ZA ZA2012/05077A patent/ZA201205077B/en unknown
- 2012-07-13 CO CO12118372A patent/CO6541655A2/es unknown
-
2014
- 2014-07-01 US US14/320,917 patent/US9265703B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
ZA201205077B (en) | 2014-12-23 |
WO2011085098A2 (en) | 2011-07-14 |
CA2786016C (en) | 2014-07-22 |
US20140314682A1 (en) | 2014-10-23 |
TW201138840A (en) | 2011-11-16 |
AU2011203624B2 (en) | 2013-06-13 |
US8784779B2 (en) | 2014-07-22 |
EP2521529A2 (en) | 2012-11-14 |
IN2012DN05919A (ja) | 2015-09-18 |
US20130195772A1 (en) | 2013-08-01 |
AR079861A1 (es) | 2012-02-22 |
AU2011203624A1 (en) | 2012-07-19 |
US9265703B2 (en) | 2016-02-23 |
BR112012016465A2 (pt) | 2019-09-24 |
RU2524631C2 (ru) | 2014-07-27 |
MY162834A (en) | 2017-07-31 |
AU2011203624B8 (en) | 2013-10-03 |
RU2012133558A (ru) | 2014-02-20 |
EP2521529B1 (en) | 2017-07-26 |
SG182302A1 (en) | 2012-08-30 |
TWI392513B (zh) | 2013-04-11 |
WO2011085098A3 (en) | 2012-07-05 |
CO6541655A2 (es) | 2012-10-16 |
CN102686211A (zh) | 2012-09-19 |
MX2012007876A (es) | 2012-08-03 |
JP2013516477A (ja) | 2013-05-13 |
CA2786016A1 (en) | 2011-07-14 |
AU2011203624A8 (en) | 2013-10-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI522117B (zh) | 具有半胱胺酸的鋅胺基酸複合物 | |
ES2683383T3 (es) | Reducción de manchas dentales derivadas de agentes antimicrobianos catiónicos | |
US20220280402A1 (en) | Aliphatic anionic compounds and oxidative compounds with improved stability and efficacy for use in pharmaceutical compositions | |
Iqbal et al. | Role of different ingredients of tooth pastes and mouthwashes in oral health | |
ES2692532T3 (es) | Medios para eliminar los alquitranes de tabaco y la composición que contiene los mismos | |
CA3020197C (en) | Aliphatic anionic compounds and oxidative compounds with improved stability and efficacy for use in pharmaceutical compositions | |
RU2457829C2 (ru) | Минерально-витаминный комплекс для укрепления эмали зубов, композиция для гигиены полости рта и зубная паста | |
JP5763676B2 (ja) | カルコン含有口腔ケア配合物の色の変化 | |
JP2015502944A (ja) | オーラルケア組成物 | |
JPH04501863A (ja) | オーラルリンス及びプラーク除去方法 | |
RU2713948C2 (ru) | Композиция для ухода за полостью рта | |
TW201334797A (zh) | 口腔護理組成物 | |
CN106413814A (zh) | 口腔护理组合物和方法 | |
US10905639B2 (en) | Tooth whitening composition | |
CA3190969A1 (en) | Oral care composition comprising hops and flavor | |
CN104135992B (zh) | 口腔护理组合物 | |
Sohta et al. | Comprehensive Review on Herbal or Medicated Toothpaste--A Review on Herbal v/s Medicated Toothpaste | |
JP2001131040A (ja) | う蝕誘発性細菌増殖抑制剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20131220 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20140129 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20140428 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20140508 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20140514 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20141225 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20150324 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20150401 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20150513 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20150611 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5763676 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
LAPS | Cancellation because of no payment of annual fees |